Maternova Social Impact exceeds 4 million lives
After ten years in business as a platform for global maternal and newborn health innovation, the company reports social impact as 4.1 million lives
Providence, Rhode Island – April 16, 2025 – Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, today announced the results of its social impact analysis covering the last ten years. The company reports 4.1 million women and infants have been impacted through the company’s unique business model.
“Maternova focuses on accelerating access to proven medical devices and diagnostics in order to prevent maternal and infant deaths. As an example, our non-pneumatic shock garment is used to reverse shock in a woman suffering from postpartum hemorrhage, the leading cause of death for women. Maternova manufactures the NASG in Asia and sells thousands of units to countries from Nicaragua to Nepal,” states the CEO, Dr. Gabriela Salvador. Another Maternova product, the MaternaWell Tray is a way to measure postpartum hemorrhage sustainably and affordably. It is being scaled up across Africa.
Each medical device or diagnostic manufactured or distributed by the company is selected for its outsized contribution to maternal, infant or child health. Products for infants include key medical equipment that should be in place in a neonatal intensive care unit (NICU) or the area of the hospital where distressed infants are nursed back to health. For example, the Pumani bubble CPAP for respiratory distress, infant warmers to treat hypothermia and other such devices are part of the Maternova product portfolio.
The company tracks the number of products sold and delivered, the countries reached and the customers’ experiences with the devices and diagnostics over time. The most recent analysis, covering 10 years in business, found that the aggregate impact of the company is 4.1 million lives.
About Maternova, Inc.
Maternova is a global health solutions company making lifesaving, evidence-based innovations accessible to low- and middle-income countries and humanitarian settings to reduce maternal and neonatal mortality and improve reproductive well-being. Founded in 2009, in 2015 it launched the first-of-its-kind marketplace for distributors, governments and humanitarian organizations to research, source and fulfill orders of trusted and rigorously tested medical devices, diagnostics and nutritional products that enhance care. Since 2015, Maternova has impacted the lives of more than 4.1 million mothers and babies around the world. Learn more about Maternova and its mission at http://www.maternova.net.
###
Media Contact:
Meg Wirth